| |
| |
|
| Insider
Information: |
Lo Andrew |
| Relationship: |
|
| City: |
Hamilton |
| State: |
D0 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
187,179 |
|
|
Indirect Shares
|
185,797,116 |
|
|
| Direct
Value |
$1,960,171 |
|
|
|
Indirect Value
|
$1,582,471,812 |
|
|
| Total
Shares |
185,984,295 |
|
|
| Total
Value |
$1,584,431,984 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
2
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-2.0
|
0.0
|
| Percentage
Gain/Loss : |
 -20.7%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Tekmira Pharmaceuticals Corp |
TKMR |
10% Owner |
|
0 |
2016-07-08 |
16,013,540 |
Premium* |
|
|
Sio Gene Therapies Inc |
SIOX |
10% Owner |
|
0 |
2019-03-18 |
105,952,381 |
Premium* |
|
|
Myovant Sciences Ltd. |
MYOV |
10% Owner |
|
0 |
2019-06-04 |
40,765,599 |
Premium* |
|
|
Urovant Sciences Ltd. |
UROV |
10% Owner |
2018-10-01 |
0 |
2019-06-19 |
22,860,013 |
Premium* |
|
|
Bridgebio Pharma, Inc. |
BBIO |
Director |
2021-12-30 |
48,099 |
2021-12-30 |
205,583 |
Premium* |
|
|
Abcellera Biologics Inc. |
ABCL |
Director |
2021-12-03 |
86,938 |
2021-12-03 |
0 |
Premium* |
|
|
Roivant Sciences Ltd. |
ROIV |
|
2022-09-15 |
52,142 |
2022-09-15 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
38 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| UROV |
Urovant Sciences Ltd. |
10% Owner |
– – • |
2019-06-13 |
4 |
AB |
$7.95 |
$58,543 |
I/I |
7,367 |
22,834,665 |
0 |
- |
|
| UROV |
Urovant Sciences Ltd. |
10% Owner |
– – • |
2019-06-11 |
4 |
AB |
$8.58 |
$61,694 |
I/I |
7,189 |
22,819,798 |
0 |
- |
|
| UROV |
Urovant Sciences Ltd. |
10% Owner |
– – • |
2019-06-12 |
4 |
AB |
$8.30 |
$62,244 |
I/I |
7,500 |
22,827,298 |
0 |
- |
|
| UROV |
Urovant Sciences Ltd. |
10% Owner |
– – • |
2019-06-10 |
4 |
AB |
$8.35 |
$62,594 |
I/I |
7,500 |
22,812,609 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
Director |
– • – |
2021-12-29 |
4 |
B |
$12.90 |
$77,400 |
D/D |
6,000 |
46,599 |
2.39 |
% |
|
| UROV |
Urovant Sciences Ltd. |
10% Owner |
– – • |
2019-05-20 |
4 |
B |
$7.98 |
$80,525 |
I/I |
10,000 |
22,725,277 |
1.5 |
- |
|
| UROV |
Urovant Sciences Ltd. |
10% Owner |
– – • |
2019-05-21 |
4 |
B |
$8.52 |
$85,108 |
I/I |
9,995 |
22,735,272 |
1.5 |
- |
|
| SIOX |
Sio Gene Therapies Inc |
10% Owner |
– – • |
2018-12-18 |
4 |
B |
$1.00 |
$10,000,000 |
I/I |
10,000,000 |
99,285,714 |
1.5 |
- |
|
| SIOX |
Sio Gene Therapies Inc |
10% Owner |
– – • |
2019-03-18 |
4 |
B |
$1.50 |
$10,000,001 |
I/I |
6,666,667 |
105,952,381 |
1.5 |
- |
|
| MYOV |
Myovant Sciences Ltd. |
10% Owner |
– – • |
2019-06-04 |
4 |
B |
$8.25 |
$19,999,997 |
I/I |
2,424,242 |
40,765,599 |
1.5 |
- |
|
| MYOV |
Myovant Sciences Ltd. |
10% Owner |
– – • |
2018-04-02 |
4 |
B |
$20.27 |
$22,500,004 |
I/I |
1,110,015 |
38,341,357 |
1.5 |
- |
|
| SIOX |
Sio Gene Therapies Inc |
10% Owner |
– – • |
2018-06-05 |
4 |
B |
$1.75 |
$25,000,000 |
I/I |
14,285,714 |
89,285,714 |
1.5 |
- |
|
| UROV |
Urovant Sciences Ltd. |
10% Owner |
– – • |
2018-10-01 |
4 |
B |
$14.00 |
$37,499,994 |
I/I |
2,678,571 |
22,703,669 |
1.5 |
- |
|
38 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
